Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

WGS

Live52w low +26.5%

Annual Quarterly

Core line items from WGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Annual Quarterly

Entity: GeneDx Holdings Corp.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-27	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$118.43M	$102.25M	$427.54M	$306.55M	$189.81M
Operating Income	Not available	$-57.47M	$-13.08M	$1.16M	$4.41M
Net Income	Not available	$-63.32M	$-21.02M	$-3.35M	$4.28M
EPS (Diluted)	$-0.03	$-2.16	$-0.73	$-0.12	$0.14
Total Assets	Not available	$506.30M	$523.71M	$493.90M	$463.86M
Total Liabilities	Not available	$252.18M	$215.53M	$201.64M	$186.73M
Cash & Equivalents	Not available	$93.92M	$105.00M	$95.97M	$74.12M
Free Cash Flow OCF − CapEx	Not available	$-38.86M	$14.26M	$21.70M	$12.10M
Shares Outstanding	Not available	29.67M	29.25M	28.89M	28.71M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from WGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +26.5%

Entity: GeneDx Holdings Corp.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-27	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$118.43M	$102.25M	$427.54M	$306.55M	$189.81M
Operating Income	Not available	$-57.47M	$-13.08M	$1.16M	$4.41M
Net Income	Not available	$-63.32M	$-21.02M	$-3.35M	$4.28M
EPS (Diluted)	$-0.03	$-2.16	$-0.73	$-0.12	$0.14
Total Assets	Not available	$506.30M	$523.71M	$493.90M	$463.86M
Total Liabilities	Not available	$252.18M	$215.53M	$201.64M	$186.73M
Cash & Equivalents	Not available	$93.92M	$105.00M	$95.97M	$74.12M
Free Cash Flow OCF − CapEx	Not available	$-38.86M	$14.26M	$21.70M	$12.10M
Shares Outstanding	Not available	29.67M	29.25M	28.89M	28.71M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.